Seres Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Seres Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2014 to Q3 2024.
  • Seres Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 170M shares, a 32.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 170M +41.6M +32.3% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 152M +23.6M +18.4% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 151M +24.8M +19.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 135M +9.82M +7.84% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 129M +4.22M +3.39% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 128M +35.7M +38.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 127M +34.4M +37.3% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 125M +33.3M +36.3% Dec 31, 2022 8-K 2024-08-15
Q3 2022 124M +32.6M +35.5% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 92.3M +593K +0.65% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 92.2M +622K +0.68% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 91.9M +430K +0.47% Dec 31, 2021 10-K 2023-03-07
Q3 2021 91.8M +627K +0.69% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 91.7M +16.6M +22.1% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 91.6M +19.9M +27.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 91.5M +21.3M +30.4% Dec 31, 2020 10-K 2022-03-01
Q3 2020 91.2M +21.2M +30.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 75.1M +5.22M +7.46% Jun 30, 2020 10-Q 2020-07-28
Q1 2020 71.7M +30.6M +74.4% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 70.1M +29.2M +71.3% Dec 31, 2019 10-K 2021-03-02
Q3 2019 70M +29.1M +71.4% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 69.9M +29.2M +71.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 41.1M +442K +1.09% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 40.9M +366K +0.9% Dec 31, 2018 10-K 2020-03-02
Q3 2018 40.8M +332K +0.82% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 40.8M +343K +0.85% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 40.7M +266K +0.66% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 40.6M +215K +0.53% Dec 31, 2017 10-K 2019-03-06
Q3 2017 40.5M +157K +0.39% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 40.4M +553K +1.39% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 40.4M +1.17M +2.98% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 40.4M +1.27M +3.26% Dec 31, 2016 10-K 2018-03-08
Q3 2016 40.4M +1.3M +3.33% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 39.9M +9.44M +31% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 39.2M Mar 31, 2016 10-Q 2016-05-16
Q4 2015 39.1M +32.2M +467% Dec 31, 2015 10-K 2017-03-16
Q3 2015 39.1M Sep 30, 2015 10-Q 2015-11-12
Q2 2015 30.4M Jun 30, 2015 10-Q 2015-08-10
Q4 2014 6.89M Dec 31, 2014 10-K 2016-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.